About me

Elías Campo is Professor of Pathology and Senior Consultant at the Hospital Clinic of Barcelona, University of Barcelona. His research focuses on the molecular and genetic characterization of lymphoid neoplasms. In the last years his work has concentrated on elucidating the genomic and functional alterations in chronic lymphocytic leukemia, mantle cell lymphoma, and other aggressive lymphomas, their role in the pathogenesis of these diseases and their impact in the clinical management of patients. He has been co-director of the Spanish CLL genome project in the International Cancer Genome Consortium. He is member of the USA National Academy of Medicine since 2018.

Featured publications

Featured Projects

  • Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

    Principal investigator: Elías Campo Güerri
    Funder: National Institute of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)
    Code: 1P01CA229100
    Duration: 01/09/2019 - 31/08/2024
  • Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)

    Principal investigator: Elías Campo Güerri
    Funder: European Commission
    Code: H2020-ERC-Sy_2018 (810287)
    Duration: 01/04/2019 - 31/03/2024
  • CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

    Principal investigator: Elías Campo Güerri
    Funder: La Caixa Foundation
    Code: HR17-00221_ LCF/PR/HR17/52150017
    Duration: 31/12/2018 - 31/12/2022
  • EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine

    Principal investigator: Elías Campo Güerri
    Funder: European Commission
    Code: CE_H2020-SC1_18_1s 825835
    Duration: 01/01/2019 - 30/06/2023
  • La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.

    Principal investigator: Elías Campo Güerri
    Funder: Generalitat de Catalunya
    Code: SLT002/16/00374
    Duration: 27/03/2017 - 31/12/2023